Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization

The authors performed a retrospective and comparative study to compare the efficacy of intravitreal aflibercept and bevacizumab for patients with myopic choroidal neovascularization (mCNV). The patients with treatment-naïve mCNV received 1 + PRN intravitreal bevacizumab from March 2008 to February 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jia-Kang, Huang, Tzu-Lun, Chang, Pei-Yao, Chen, Yen-Ting, Chang, Chin-Wei, Chen, Fang-Ting, Hsu, Yung-Ray, Chen, Yun-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158246/
https://www.ncbi.nlm.nih.gov/pubmed/30258077
http://dx.doi.org/10.1038/s41598-018-32761-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158246/
https://www.ncbi.nlm.nih.gov/pubmed/30258077
http://dx.doi.org/10.1038/s41598-018-32761-z

Ejemplares similares